NCT07004335
- Conditions
- Advanced Melanoma, Bevacizumab, CTLA-4, +4 more
- Locations
-
- The Fourth Hospital of Hebei Medical University Shijiazhuang, China
Clinical trial condition
Explore clinical trials studying Iparomlimab. Study availability and eligibility vary by location and protocol.
NCT07004335